Non-alcoholic fatty liver disease in diabetics - prevalence and predictive factors in a multiracial hospital clinic population in Malaysia

被引:58
|
作者
Chan, Wah-Kheong [1 ]
Tan, Alexander Tong-Boon [2 ]
Vethakkan, Shireene Ratna [2 ]
Tah, Pei-Chien [3 ]
Vijayananthan, Anushya [4 ]
Goh, Khean-Lee [1 ]
机构
[1] Univ Malaya, Fac Med, Gastroenterol & Hepatol Unit, Gastrointestinal Endoscopy Unit,Dept Med, Kuala Lumpur 50603, Malaysia
[2] Univ Malaya, Fac Med, Dept Med, Endocrinol Unit, Kuala Lumpur 50603, Malaysia
[3] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur 50603, Malaysia
[4] Univ Malaya, Med Ctr, Dept Dietet, Kuala Lumpur 50603, Malaysia
关键词
diabetes mellitus; dietary intake; epidemiology; ethnicity; non-alcoholic fatty liver disease; physical activity; METABOLIC SYNDROME; CIRRHOSIS; NAFLD; EPIDEMIOLOGY; VARIABILITY; DIAGNOSIS; FIBROSIS;
D O I
10.1111/jgh.12204
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: There is currently no published study comparing prevalence of non-alcoholic fatty liver disease (NAFLD) and associated factors among diabetics of different ethnicity in the Asia-Pacific region. Methods: Cross-sectional study of consecutive patients in the Diabetic Clinic in University of Malaya Medical Centre. The Global Physical Activity Questionnaire and a semi-quantitative food-frequency questionnaire were used to assess physical activity and dietary intake, respectively. Diagnosis of NAFLD was ultrasound-based and following exclusion of significant alcohol intake. Results: Data for 399 patients were analyzed (mean age 62.3 +/- 10.5 years, 43.1% men). The racial distribution was Chinese 43.6%, Indian 33.1%, Malay 22.3%, and others 1.0%. The prevalence of NAFLD was 49.6%. On univariate analysis, factors associated with NAFLD were age < 65 years, race, obesity, central obesity, glycated hemoglobin >= 7.0%, and elevated serum alanine aminotransferase (ALT) and gamma-glutamyl transpeptidase levels. Patients with low physical activity were more likely to have NAFLD (odds ratio [OR] = 1.67, 95% confidence interval [CI] = 1.06-2.63, P = 0.020). The prevalence of NAFLD was highest among Malays (60.7%), followed by Indians (51.5%), and lowest among Chinese (42.0%) consistent with higher prevalence of central obesity and higher percentage calorie intake from fat in the former groups of patients. On multivariate analysis, independent factors associated with NAFLD were central obesity (OR = 2.20, 95% CI = 1.29-3.75, P = 0.004) and elevated serum ALT level (OR = 1.98, 95% CI = 1.21-3.25, P = 0.007). Conclusions: NAFLD was seen in half of a cohort of diabetic patients and was independently associated with central obesity and elevated serum ALT level. Prevalence of NAFLD was different and paralleled the difference in prevalence of central obesity and in percentage calorie intake from fat among the different ethnic groups.
引用
收藏
页码:1375 / 1383
页数:9
相关论文
共 50 条
  • [31] Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis
    Sharma, Praveen
    Arora, Anil
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [32] Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease
    Kamarajah, Sivesh K.
    Chan, Wah-Kheong
    Mustapha, Nik Raihan Nik
    Mahadeva, Sanjiv
    HEPATOLOGY INTERNATIONAL, 2018, 12 (01) : 44 - 55
  • [33] Prevalence of Non-alcoholic Fatty Liver Disease Detected by Computed Tomography in the General Population Compared with Ultrasonography
    Ito, Yuki
    Yoshioka, Kentaro
    Hayashi, Kazuhiko
    Shimizu, Yuko
    Fujimoto, Ryo
    Yamane, Ryosuke
    Yoshizaki, Michiyo
    Kajikawa, Go
    Mizutani, Taro
    Goto, Hidemi
    INTERNAL MEDICINE, 2024, 63 (02) : 159 - 167
  • [34] Prevalence of non-alcoholic fatty liver disease among diabetes, prediabetes and healthy population
    Kumar, Pratyush
    Rawat, Sonia
    Kakar, Atul
    Sinha, Abhay K.
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (12) : 7640 - 7643
  • [35] The epidemiology of non-alcoholic fatty liver disease
    Bellentani, Stefano
    LIVER INTERNATIONAL, 2017, 37 : 81 - 84
  • [36] Pathology of non-alcoholic fatty liver disease
    Cataldo, Ivana
    Sarcognato, Samantha
    Sacchi, Diana
    Cacciatore, Matilde
    Baciorri, Francesca
    Mangia, Alessandra
    Cazzagon, Nora
    Guido, Maria
    PATHOLOGICA, 2021, 113 (03) : 194 - 202
  • [37] Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population
    Sayiner, Mehmet
    Arshad, Tamoore
    Golabi, Pegah
    Paik, James
    Farhat, Freba
    Younossi, Zobair M.
    HEPATOLOGY INTERNATIONAL, 2020, 14 (04) : 556 - 566
  • [38] Comparative analysis of metabolic risk factors for progression of non-alcoholic fatty liver disease
    Yao, Vincent J. H.
    Sun, Michael
    Rahman, Aivi A.
    Samuel, Zachariah
    Chan, Joyce
    Zheng, Elizabeth
    Yao, Alan C.
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (02) : 241 - 247
  • [39] Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study
    Onwuzo, Somtochukwu Stephen
    Hitawala, Asif Ali
    Boustany, Antoine
    Kumar, Prabhat
    Almomani, Ashraf
    Onwuzo, Chidera
    Monteiro, Jessy Mascarenhas
    Asaad, Imad
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (02) : 265 - 273
  • [40] Epidemiology of Non-Alcoholic Fatty Liver Disease
    Bellentani, Stefano
    Scaglioni, Federica
    Marino, Mariano
    Bedogni, Giorgio
    DIGESTIVE DISEASES, 2010, 28 (01) : 155 - 161